Acute Myeloid Leukaemia
Clinical criteria:
-
The treatment must be used in combination with venetoclax (refer to Product Information for timing of azacitidine and venetoclax doses).
Acute Myeloid Leukaemia
Clinical criteria:
The treatment must be used in combination with venetoclax (refer to Product Information for timing of azacitidine and venetoclax doses).
Applications for authorisation under this restriction may be made in real time using the Online PBS Authorities system (see www.servicesaustralia.gov.au/HPOS) or by telephone by contacting Services Australia on 1800 700 270 (hours of operation 8 a.m. to 5 p.m. Monday to Friday).